1Kahn SE. Clinical review 135:The importance of beta- cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;Sep;86(9) :4047 - 58.
2Deng S, Vatamaniuk M, Huang X, et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004;Mar, 53(3) :624 - 32.
3Rhodes CJ. Type 2 diabetes - a matter of beta - cell life and death? Science.2005 Jan 21;307(5708) :380 - 4.
4Bouwens L, Rooman I. Regulation of pancreatic beta - cell mass. Physiol Rev.2005 Oct;85(4):1255 -70
5Weir G, Bonner - Weir S, Five stages of evolving beta - cell dysfunction during progression to diabetes, Diabetes 2004; Dec, 53 Suppl 3 : S16 - 21
6Matveyenko AV, Butler PC. Beta - cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (H1P) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 2006;Jul;55(7) :2106 - 14.
7Butler AE, Janson J, Bonner - Weir S, et al. Beta - cell deficit and increased beta - cell apoptosis in humans with type 2 diabetes. Diabetes 2003 ;Jan; 52(1) : 102 - 10.
8Yoon KH, Ko SH, Cho JH, et al. Selective beta - cell loss and alpha - cell expansion in patients with type 2 diabetes meilitus in Korea.J Clin Endocrinol Metab 2003;May;88(5) :2300-8.
9Larsen MO, Rolin B, Sturis J, et al. Measurements of insulin responses as predictive markers of pancreatic beta - cell mass in normal and beta - cell - reduced lean and obese Gottingen minipigs in vivo. Am J Physiol Endocrinol Metab 2006;Apr;290(4):E670-7.
10Lin JM, Fabregat ME, Gomis R, et al. Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. Diabetes 2002;Apt;51(4) :988 - 93.
